Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 4:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 3,875 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: fast Clear all

Conditions: Healthy Volunteers
Interventions: Maribavir; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Carotid Artery Disease
Interventions: Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 38
States / cities: Fremont, California • Mountain View, California • Newport Beach, California + 35 more

Conditions: Congenital Hyperinsulinism
Interventions: Exendin-(9-39), Vehicle; Drug · Other
Lead sponsor: Diva De Leon; Other
Eligibility: 7 Years to 60 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy
Interventions: Gabapentin 800 mg Tablets, single dose, NEURONTIN® 800 mg Tablets, single dose; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Peripheral Artery Disease
Interventions: Fitbit Physical Activity Monitor, mHealth Glucometer, mHealth Blood Pressure; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoarthritis, Knee
Interventions: Exercise; Behavioral
Lead sponsor: Helen Hayes Hospital; Other
Eligibility: 60 Years to 89 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: West Haverstraw, New York

Conditions: Intracranial Aneurysm
Interventions: Comaneci Embolization Assist Device; Device
Lead sponsor: Rapid Medical; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 8
States / cities: Mobile, Alabama • Tucson, Arizona • Santa Barbara, California + 5 more

Conditions: Malaria Falciparum, Malaria Vivax, Healthy Volunteers
Interventions: OZ439 50mg API capsules, OZ439 200mg API capsules, OZ439 400mg aqueous dispersion, OZ439 800mg aqueous dispersion, OZ439 100mg API capsules, OZ439 400mg API capsules, OZ439 1600mg aqueous dispersion, OZ439 800mg API capsules, OZ439 1200mg API capsules, Placebo, OZ439 200mg aqueous dispersion; Drug
Lead sponsor: Medicines for Malaria Venture; Other
Eligibility: 18 Years to 55 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Miramar, Florida

Conditions: Glioblastoma Multiforme, Anaplastic Glioma
Interventions: Temodar and O6-Benzylguanine (BG); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Gestational Diabetes, Pregnancy, Glucose Intolerance
Interventions: Gestational diabetes screening with fasting 3 hour 100 gm, Gestational diabetes screening with fasting 2 hour 75g; Diagnostic Test
Lead sponsor: Esa M Davis, MD MPH FAAFP; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 921 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy Volunteer
Interventions: TPI-120 Pre-Filled Syringe 6 mg/0.6 mL; Biological
Lead sponsor: Kashiv BioSciences, LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Hepatitis C
Interventions: ABT-072, Placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Waukegan, Illinois

Conditions: Overweight and Obesity, Time Restricted Feeding, Alzheimer Disease
Interventions: Time Restricted Eating intervention, Successful Aging Comparison Group (LEARN); Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 65 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: HIV, Hepatitis C
Interventions: Questionnaire, Rapid finger stick, Venipuncture; Behavioral · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Long COVID, Insulin Resistance, Insulin Sensitivity
Interventions: Adipose Tissue Biopsy, Steady State Plasma Glucose (SSPG) Test; Procedure · Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Palo Alto, California

Conditions: Food Insecurity
Interventions: Prepared Meals, Grocery Gift Cards, Standard of Care; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy
Interventions: Metformin HCl 500 mg tablets, single dose, CLUCOPHAGE® XR 500 mg tablets, single dose; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Cystic Fibrosis (CF)
Interventions: Two-Bronchoscope Technique; Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Cystic Fibrosis, Sickle Cell Disease, SARS CoV 2 Infection
Interventions: Exercise; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 10 Years to 17 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: PTSD
Interventions: acupuncture; Procedure
Lead sponsor: Malcolm Grow Medical Clinics and Surgery Center; Federal
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Morningside, Maryland

Conditions: Anxiety Disorders
Interventions: FSET Anxiety and Sleep Treatment, Control; Other
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Stakeholder Engagement
Interventions: Standard engagement approach, Agile methods engagement approach; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Not listed
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: COVID-19, Influenza A, Influenza Type B
Interventions: Panbio™; Diagnostic Test
Lead sponsor: Abbott Rapid Dx; Industry
Eligibility: Not listed
Enrollment: 903 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Easley, South Carolina

Conditions: Anterior Knee Pain Syndrome, Patellofemoral Pain Syndrome
Interventions: Dry Needling, Soft Tissue Mobilization, Placebo Control, Hip and core strengthening exercises; Other
Lead sponsor: Mitchell Selhorst; Other
Eligibility: 13 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions

Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)

A Comparative Analysis of Two Types of Exercise on Outcomes Following Total Knee Arthroplasty

Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects

Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma

Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)

Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy Adults

Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072

Fasting ENHANCE Pilot Study

Integrating HCV and HIV Screening During the Era of HIV Antigen Testing

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

Nurturing Outreach for Understanding and Reducing Inpatient Security of Health

A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions

Evaluation Of The Pan-microbiome and Host Immune Response in CF

Exercise in Child Health

Rapid Acupuncture Treatment for Post-Traumatic Stress Disorder

Transdiagnostic Sleep and Anxiety Treatment

PRECIDENTD Engagement Methods for Sites

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device

Manual Therapy to Treat Gluteus Medius Trigger Points